Global Hyperimmune Globulins Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hyperimmune Globulins market size is predicted to grow from US$ 2014 million in 2025 to US$ 3066 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent. In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.
However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.
LP Information, Inc. (LPI) ' newest research report, the “Hyperimmune Globulins Industry Forecast” looks at past sales and reviews total world Hyperimmune Globulins sales in 2024, providing a comprehensive analysis by region and market sector of projected Hyperimmune Globulins sales for 2025 through 2031. With Hyperimmune Globulins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Globulins industry.
This Insight Report provides a comprehensive analysis of the global Hyperimmune Globulins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Globulins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hyperimmune Globulins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Globulins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Globulins.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hyperimmune Globulins market?
What factors are driving Hyperimmune Globulins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyperimmune Globulins market opportunities vary by end market size?
How does Hyperimmune Globulins break out by Type, by Application?
The global Hyperimmune Globulins market size is predicted to grow from US$ 2014 million in 2025 to US$ 3066 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent. In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.
However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.
LP Information, Inc. (LPI) ' newest research report, the “Hyperimmune Globulins Industry Forecast” looks at past sales and reviews total world Hyperimmune Globulins sales in 2024, providing a comprehensive analysis by region and market sector of projected Hyperimmune Globulins sales for 2025 through 2031. With Hyperimmune Globulins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperimmune Globulins industry.
This Insight Report provides a comprehensive analysis of the global Hyperimmune Globulins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperimmune Globulins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hyperimmune Globulins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperimmune Globulins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperimmune Globulins.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Hepatitis B Immunoglobulins
- Rabies Immunoglobulins
- Tetanus Immunoglobulins
- Rho(D) Immunoglobulins
- Herpes Zoster Immune Globulin
- Other
- Government Institutions
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Biotest
- Kedrion
- CBPO
- Emergent (Cangene)
- Kamada
- CNBG
- Hualan Bio
- Shanghai RAAS
- Sichuan Yuanda Shuyang
- ADMA Biologics
What is the 10-year outlook for the global Hyperimmune Globulins market?
What factors are driving Hyperimmune Globulins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hyperimmune Globulins market opportunities vary by end market size?
How does Hyperimmune Globulins break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyperimmune Globulins Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hyperimmune Globulins by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hyperimmune Globulins by Country/Region, 2020, 2024 & 2031
2.2 Hyperimmune Globulins Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Herpes Zoster Immune Globulin
2.2.6 Other
2.3 Hyperimmune Globulins Sales by Type
2.3.1 Global Hyperimmune Globulins Sales Market Share by Type (2020-2025)
2.3.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hyperimmune Globulins Sale Price by Type (2020-2025)
2.4 Hyperimmune Globulins Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Globulins Sales by Application
2.5.1 Global Hyperimmune Globulins Sale Market Share by Application (2020-2025)
2.5.2 Global Hyperimmune Globulins Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hyperimmune Globulins Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hyperimmune Globulins Breakdown Data by Company
3.1.1 Global Hyperimmune Globulins Annual Sales by Company (2020-2025)
3.1.2 Global Hyperimmune Globulins Sales Market Share by Company (2020-2025)
3.2 Global Hyperimmune Globulins Annual Revenue by Company (2020-2025)
3.2.1 Global Hyperimmune Globulins Revenue by Company (2020-2025)
3.2.2 Global Hyperimmune Globulins Revenue Market Share by Company (2020-2025)
3.3 Global Hyperimmune Globulins Sale Price by Company
3.4 Key Manufacturers Hyperimmune Globulins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperimmune Globulins Product Location Distribution
3.4.2 Players Hyperimmune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HYPERIMMUNE GLOBULINS BY GEOGRAPHIC REGION
4.1 World Historic Hyperimmune Globulins Market Size by Geographic Region (2020-2025)
4.1.1 Global Hyperimmune Globulins Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hyperimmune Globulins Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hyperimmune Globulins Market Size by Country/Region (2020-2025)
4.2.1 Global Hyperimmune Globulins Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hyperimmune Globulins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hyperimmune Globulins Sales Growth
4.4 APAC Hyperimmune Globulins Sales Growth
4.5 Europe Hyperimmune Globulins Sales Growth
4.6 Middle East & Africa Hyperimmune Globulins Sales Growth
5 AMERICAS
5.1 Americas Hyperimmune Globulins Sales by Country
5.1.1 Americas Hyperimmune Globulins Sales by Country (2020-2025)
5.1.2 Americas Hyperimmune Globulins Revenue by Country (2020-2025)
5.2 Americas Hyperimmune Globulins Sales by Type (2020-2025)
5.3 Americas Hyperimmune Globulins Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperimmune Globulins Sales by Region
6.1.1 APAC Hyperimmune Globulins Sales by Region (2020-2025)
6.1.2 APAC Hyperimmune Globulins Revenue by Region (2020-2025)
6.2 APAC Hyperimmune Globulins Sales by Type (2020-2025)
6.3 APAC Hyperimmune Globulins Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyperimmune Globulins by Country
7.1.1 Europe Hyperimmune Globulins Sales by Country (2020-2025)
7.1.2 Europe Hyperimmune Globulins Revenue by Country (2020-2025)
7.2 Europe Hyperimmune Globulins Sales by Type (2020-2025)
7.3 Europe Hyperimmune Globulins Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyperimmune Globulins by Country
8.1.1 Middle East & Africa Hyperimmune Globulins Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hyperimmune Globulins Revenue by Country (2020-2025)
8.2 Middle East & Africa Hyperimmune Globulins Sales by Type (2020-2025)
8.3 Middle East & Africa Hyperimmune Globulins Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperimmune Globulins
10.3 Manufacturing Process Analysis of Hyperimmune Globulins
10.4 Industry Chain Structure of Hyperimmune Globulins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperimmune Globulins Distributors
11.3 Hyperimmune Globulins Customer
12 WORLD FORECAST REVIEW FOR HYPERIMMUNE GLOBULINS BY GEOGRAPHIC REGION
12.1 Global Hyperimmune Globulins Market Size Forecast by Region
12.1.1 Global Hyperimmune Globulins Forecast by Region (2026-2031)
12.1.2 Global Hyperimmune Globulins Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hyperimmune Globulins Forecast by Type (2026-2031)
12.7 Global Hyperimmune Globulins Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyperimmune Globulins Product Portfolios and Specifications
13.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyperimmune Globulins Product Portfolios and Specifications
13.2.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyperimmune Globulins Product Portfolios and Specifications
13.3.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyperimmune Globulins Product Portfolios and Specifications
13.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyperimmune Globulins Product Portfolios and Specifications
13.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyperimmune Globulins Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyperimmune Globulins Product Portfolios and Specifications
13.7.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyperimmune Globulins Product Portfolios and Specifications
13.8.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyperimmune Globulins Product Portfolios and Specifications
13.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyperimmune Globulins Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyperimmune Globulins Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hyperimmune Globulins Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hyperimmune Globulins by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hyperimmune Globulins by Country/Region, 2020, 2024 & 2031
2.2 Hyperimmune Globulins Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Herpes Zoster Immune Globulin
2.2.6 Other
2.3 Hyperimmune Globulins Sales by Type
2.3.1 Global Hyperimmune Globulins Sales Market Share by Type (2020-2025)
2.3.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hyperimmune Globulins Sale Price by Type (2020-2025)
2.4 Hyperimmune Globulins Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Globulins Sales by Application
2.5.1 Global Hyperimmune Globulins Sale Market Share by Application (2020-2025)
2.5.2 Global Hyperimmune Globulins Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hyperimmune Globulins Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hyperimmune Globulins Breakdown Data by Company
3.1.1 Global Hyperimmune Globulins Annual Sales by Company (2020-2025)
3.1.2 Global Hyperimmune Globulins Sales Market Share by Company (2020-2025)
3.2 Global Hyperimmune Globulins Annual Revenue by Company (2020-2025)
3.2.1 Global Hyperimmune Globulins Revenue by Company (2020-2025)
3.2.2 Global Hyperimmune Globulins Revenue Market Share by Company (2020-2025)
3.3 Global Hyperimmune Globulins Sale Price by Company
3.4 Key Manufacturers Hyperimmune Globulins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hyperimmune Globulins Product Location Distribution
3.4.2 Players Hyperimmune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HYPERIMMUNE GLOBULINS BY GEOGRAPHIC REGION
4.1 World Historic Hyperimmune Globulins Market Size by Geographic Region (2020-2025)
4.1.1 Global Hyperimmune Globulins Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hyperimmune Globulins Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hyperimmune Globulins Market Size by Country/Region (2020-2025)
4.2.1 Global Hyperimmune Globulins Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hyperimmune Globulins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hyperimmune Globulins Sales Growth
4.4 APAC Hyperimmune Globulins Sales Growth
4.5 Europe Hyperimmune Globulins Sales Growth
4.6 Middle East & Africa Hyperimmune Globulins Sales Growth
5 AMERICAS
5.1 Americas Hyperimmune Globulins Sales by Country
5.1.1 Americas Hyperimmune Globulins Sales by Country (2020-2025)
5.1.2 Americas Hyperimmune Globulins Revenue by Country (2020-2025)
5.2 Americas Hyperimmune Globulins Sales by Type (2020-2025)
5.3 Americas Hyperimmune Globulins Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hyperimmune Globulins Sales by Region
6.1.1 APAC Hyperimmune Globulins Sales by Region (2020-2025)
6.1.2 APAC Hyperimmune Globulins Revenue by Region (2020-2025)
6.2 APAC Hyperimmune Globulins Sales by Type (2020-2025)
6.3 APAC Hyperimmune Globulins Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hyperimmune Globulins by Country
7.1.1 Europe Hyperimmune Globulins Sales by Country (2020-2025)
7.1.2 Europe Hyperimmune Globulins Revenue by Country (2020-2025)
7.2 Europe Hyperimmune Globulins Sales by Type (2020-2025)
7.3 Europe Hyperimmune Globulins Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hyperimmune Globulins by Country
8.1.1 Middle East & Africa Hyperimmune Globulins Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hyperimmune Globulins Revenue by Country (2020-2025)
8.2 Middle East & Africa Hyperimmune Globulins Sales by Type (2020-2025)
8.3 Middle East & Africa Hyperimmune Globulins Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperimmune Globulins
10.3 Manufacturing Process Analysis of Hyperimmune Globulins
10.4 Industry Chain Structure of Hyperimmune Globulins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hyperimmune Globulins Distributors
11.3 Hyperimmune Globulins Customer
12 WORLD FORECAST REVIEW FOR HYPERIMMUNE GLOBULINS BY GEOGRAPHIC REGION
12.1 Global Hyperimmune Globulins Market Size Forecast by Region
12.1.1 Global Hyperimmune Globulins Forecast by Region (2026-2031)
12.1.2 Global Hyperimmune Globulins Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hyperimmune Globulins Forecast by Type (2026-2031)
12.7 Global Hyperimmune Globulins Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Hyperimmune Globulins Product Portfolios and Specifications
13.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Hyperimmune Globulins Product Portfolios and Specifications
13.2.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Hyperimmune Globulins Product Portfolios and Specifications
13.3.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kedrion
13.4.1 Kedrion Company Information
13.4.2 Kedrion Hyperimmune Globulins Product Portfolios and Specifications
13.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kedrion Main Business Overview
13.4.5 Kedrion Latest Developments
13.5 CBPO
13.5.1 CBPO Company Information
13.5.2 CBPO Hyperimmune Globulins Product Portfolios and Specifications
13.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CBPO Main Business Overview
13.5.5 CBPO Latest Developments
13.6 Emergent (Cangene)
13.6.1 Emergent (Cangene) Company Information
13.6.2 Emergent (Cangene) Hyperimmune Globulins Product Portfolios and Specifications
13.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Emergent (Cangene) Main Business Overview
13.6.5 Emergent (Cangene) Latest Developments
13.7 Kamada
13.7.1 Kamada Company Information
13.7.2 Kamada Hyperimmune Globulins Product Portfolios and Specifications
13.7.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Kamada Main Business Overview
13.7.5 Kamada Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Hyperimmune Globulins Product Portfolios and Specifications
13.8.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Hualan Bio
13.9.1 Hualan Bio Company Information
13.9.2 Hualan Bio Hyperimmune Globulins Product Portfolios and Specifications
13.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hualan Bio Main Business Overview
13.9.5 Hualan Bio Latest Developments
13.10 Shanghai RAAS
13.10.1 Shanghai RAAS Company Information
13.10.2 Shanghai RAAS Hyperimmune Globulins Product Portfolios and Specifications
13.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shanghai RAAS Main Business Overview
13.10.5 Shanghai RAAS Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolios and Specifications
13.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 ADMA Biologics
13.12.1 ADMA Biologics Company Information
13.12.2 ADMA Biologics Hyperimmune Globulins Product Portfolios and Specifications
13.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 ADMA Biologics Main Business Overview
13.12.5 ADMA Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hyperimmune Globulins Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hyperimmune Globulins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Herpes Zoster Immune Globulin
Table 8. Major Players of Other
Table 9. Global Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 10. Global Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Table 11. Global Hyperimmune Globulins Revenue by Type (2020-2025) & ($ million)
Table 12. Global Hyperimmune Globulins Revenue Market Share by Type (2020-2025)
Table 13. Global Hyperimmune Globulins Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Hyperimmune Globulins Sale by Application (2020-2025) & (K Units)
Table 15. Global Hyperimmune Globulins Sale Market Share by Application (2020-2025)
Table 16. Global Hyperimmune Globulins Revenue by Application (2020-2025) & ($ million)
Table 17. Global Hyperimmune Globulins Revenue Market Share by Application (2020-2025)
Table 18. Global Hyperimmune Globulins Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Hyperimmune Globulins Sales by Company (2020-2025) & (K Units)
Table 20. Global Hyperimmune Globulins Sales Market Share by Company (2020-2025)
Table 21. Global Hyperimmune Globulins Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Hyperimmune Globulins Revenue Market Share by Company (2020-2025)
Table 23. Global Hyperimmune Globulins Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Hyperimmune Globulins Producing Area Distribution and Sales Area
Table 25. Players Hyperimmune Globulins Products Offered
Table 26. Hyperimmune Globulins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Hyperimmune Globulins Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Hyperimmune Globulins Sales Market Share Geographic Region (2020-2025)
Table 31. Global Hyperimmune Globulins Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Hyperimmune Globulins Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Hyperimmune Globulins Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Hyperimmune Globulins Sales Market Share by Country/Region (2020-2025)
Table 35. Global Hyperimmune Globulins Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Hyperimmune Globulins Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 38. Americas Hyperimmune Globulins Sales Market Share by Country (2020-2025)
Table 39. Americas Hyperimmune Globulins Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 41. Americas Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 42. APAC Hyperimmune Globulins Sales by Region (2020-2025) & (K Units)
Table 43. APAC Hyperimmune Globulins Sales Market Share by Region (2020-2025)
Table 44. APAC Hyperimmune Globulins Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 46. APAC Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 47. Europe Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 48. Europe Hyperimmune Globulins Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 50. Europe Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Hyperimmune Globulins
Table 56. Key Market Challenges & Risks of Hyperimmune Globulins
Table 57. Key Industry Trends of Hyperimmune Globulins
Table 58. Hyperimmune Globulins Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Hyperimmune Globulins Distributors List
Table 61. Hyperimmune Globulins Customer List
Table 62. Global Hyperimmune Globulins Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Hyperimmune Globulins Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Hyperimmune Globulins Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Hyperimmune Globulins Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Hyperimmune Globulins Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Hyperimmune Globulins Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Hyperimmune Globulins Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Hyperimmune Globulins Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Hyperimmune Globulins Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Hyperimmune Globulins Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Hyperimmune Globulins Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. CSL Behring Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 77. CSL Behring Hyperimmune Globulins Product Portfolios and Specifications
Table 78. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. CSL Behring Main Business
Table 80. CSL Behring Latest Developments
Table 81. Grifols Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 82. Grifols Hyperimmune Globulins Product Portfolios and Specifications
Table 83. Grifols Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Grifols Main Business
Table 85. Grifols Latest Developments
Table 86. Biotest Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 87. Biotest Hyperimmune Globulins Product Portfolios and Specifications
Table 88. Biotest Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Biotest Main Business
Table 90. Biotest Latest Developments
Table 91. Kedrion Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 92. Kedrion Hyperimmune Globulins Product Portfolios and Specifications
Table 93. Kedrion Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Kedrion Main Business
Table 95. Kedrion Latest Developments
Table 96. CBPO Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 97. CBPO Hyperimmune Globulins Product Portfolios and Specifications
Table 98. CBPO Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. CBPO Main Business
Table 100. CBPO Latest Developments
Table 101. Emergent (Cangene) Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 102. Emergent (Cangene) Hyperimmune Globulins Product Portfolios and Specifications
Table 103. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Emergent (Cangene) Main Business
Table 105. Emergent (Cangene) Latest Developments
Table 106. Kamada Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 107. Kamada Hyperimmune Globulins Product Portfolios and Specifications
Table 108. Kamada Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Kamada Main Business
Table 110. Kamada Latest Developments
Table 111. CNBG Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 112. CNBG Hyperimmune Globulins Product Portfolios and Specifications
Table 113. CNBG Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. CNBG Main Business
Table 115. CNBG Latest Developments
Table 116. Hualan Bio Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 117. Hualan Bio Hyperimmune Globulins Product Portfolios and Specifications
Table 118. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Hualan Bio Main Business
Table 120. Hualan Bio Latest Developments
Table 121. Shanghai RAAS Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 122. Shanghai RAAS Hyperimmune Globulins Product Portfolios and Specifications
Table 123. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Shanghai RAAS Main Business
Table 125. Shanghai RAAS Latest Developments
Table 126. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 127. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolios and Specifications
Table 128. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Sichuan Yuanda Shuyang Main Business
Table 130. Sichuan Yuanda Shuyang Latest Developments
Table 131. ADMA Biologics Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 132. ADMA Biologics Hyperimmune Globulins Product Portfolios and Specifications
Table 133. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. ADMA Biologics Main Business
Table 135. ADMA Biologics Latest Developments
Table 1. Hyperimmune Globulins Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hyperimmune Globulins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hepatitis B Immunoglobulins
Table 4. Major Players of Rabies Immunoglobulins
Table 5. Major Players of Tetanus Immunoglobulins
Table 6. Major Players of Rho(D) Immunoglobulins
Table 7. Major Players of Herpes Zoster Immune Globulin
Table 8. Major Players of Other
Table 9. Global Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 10. Global Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Table 11. Global Hyperimmune Globulins Revenue by Type (2020-2025) & ($ million)
Table 12. Global Hyperimmune Globulins Revenue Market Share by Type (2020-2025)
Table 13. Global Hyperimmune Globulins Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Hyperimmune Globulins Sale by Application (2020-2025) & (K Units)
Table 15. Global Hyperimmune Globulins Sale Market Share by Application (2020-2025)
Table 16. Global Hyperimmune Globulins Revenue by Application (2020-2025) & ($ million)
Table 17. Global Hyperimmune Globulins Revenue Market Share by Application (2020-2025)
Table 18. Global Hyperimmune Globulins Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Hyperimmune Globulins Sales by Company (2020-2025) & (K Units)
Table 20. Global Hyperimmune Globulins Sales Market Share by Company (2020-2025)
Table 21. Global Hyperimmune Globulins Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Hyperimmune Globulins Revenue Market Share by Company (2020-2025)
Table 23. Global Hyperimmune Globulins Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Hyperimmune Globulins Producing Area Distribution and Sales Area
Table 25. Players Hyperimmune Globulins Products Offered
Table 26. Hyperimmune Globulins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Hyperimmune Globulins Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Hyperimmune Globulins Sales Market Share Geographic Region (2020-2025)
Table 31. Global Hyperimmune Globulins Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Hyperimmune Globulins Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Hyperimmune Globulins Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Hyperimmune Globulins Sales Market Share by Country/Region (2020-2025)
Table 35. Global Hyperimmune Globulins Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Hyperimmune Globulins Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 38. Americas Hyperimmune Globulins Sales Market Share by Country (2020-2025)
Table 39. Americas Hyperimmune Globulins Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 41. Americas Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 42. APAC Hyperimmune Globulins Sales by Region (2020-2025) & (K Units)
Table 43. APAC Hyperimmune Globulins Sales Market Share by Region (2020-2025)
Table 44. APAC Hyperimmune Globulins Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 46. APAC Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 47. Europe Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 48. Europe Hyperimmune Globulins Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 50. Europe Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Hyperimmune Globulins Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Hyperimmune Globulins Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Hyperimmune Globulins
Table 56. Key Market Challenges & Risks of Hyperimmune Globulins
Table 57. Key Industry Trends of Hyperimmune Globulins
Table 58. Hyperimmune Globulins Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Hyperimmune Globulins Distributors List
Table 61. Hyperimmune Globulins Customer List
Table 62. Global Hyperimmune Globulins Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Hyperimmune Globulins Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Hyperimmune Globulins Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Hyperimmune Globulins Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Hyperimmune Globulins Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Hyperimmune Globulins Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Hyperimmune Globulins Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Hyperimmune Globulins Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Hyperimmune Globulins Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Hyperimmune Globulins Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Hyperimmune Globulins Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Hyperimmune Globulins Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. CSL Behring Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 77. CSL Behring Hyperimmune Globulins Product Portfolios and Specifications
Table 78. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. CSL Behring Main Business
Table 80. CSL Behring Latest Developments
Table 81. Grifols Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 82. Grifols Hyperimmune Globulins Product Portfolios and Specifications
Table 83. Grifols Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Grifols Main Business
Table 85. Grifols Latest Developments
Table 86. Biotest Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 87. Biotest Hyperimmune Globulins Product Portfolios and Specifications
Table 88. Biotest Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Biotest Main Business
Table 90. Biotest Latest Developments
Table 91. Kedrion Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 92. Kedrion Hyperimmune Globulins Product Portfolios and Specifications
Table 93. Kedrion Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Kedrion Main Business
Table 95. Kedrion Latest Developments
Table 96. CBPO Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 97. CBPO Hyperimmune Globulins Product Portfolios and Specifications
Table 98. CBPO Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. CBPO Main Business
Table 100. CBPO Latest Developments
Table 101. Emergent (Cangene) Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 102. Emergent (Cangene) Hyperimmune Globulins Product Portfolios and Specifications
Table 103. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Emergent (Cangene) Main Business
Table 105. Emergent (Cangene) Latest Developments
Table 106. Kamada Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 107. Kamada Hyperimmune Globulins Product Portfolios and Specifications
Table 108. Kamada Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Kamada Main Business
Table 110. Kamada Latest Developments
Table 111. CNBG Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 112. CNBG Hyperimmune Globulins Product Portfolios and Specifications
Table 113. CNBG Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. CNBG Main Business
Table 115. CNBG Latest Developments
Table 116. Hualan Bio Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 117. Hualan Bio Hyperimmune Globulins Product Portfolios and Specifications
Table 118. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Hualan Bio Main Business
Table 120. Hualan Bio Latest Developments
Table 121. Shanghai RAAS Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 122. Shanghai RAAS Hyperimmune Globulins Product Portfolios and Specifications
Table 123. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Shanghai RAAS Main Business
Table 125. Shanghai RAAS Latest Developments
Table 126. Sichuan Yuanda Shuyang Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 127. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolios and Specifications
Table 128. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Sichuan Yuanda Shuyang Main Business
Table 130. Sichuan Yuanda Shuyang Latest Developments
Table 131. ADMA Biologics Basic Information, Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 132. ADMA Biologics Hyperimmune Globulins Product Portfolios and Specifications
Table 133. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. ADMA Biologics Main Business
Table 135. ADMA Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hyperimmune Globulins
Figure 2. Hyperimmune Globulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperimmune Globulins Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hyperimmune Globulins Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hyperimmune Globulins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hyperimmune Globulins Sales Market Share by Country/Region (2024)
Figure 10. Hyperimmune Globulins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Hepatitis B Immunoglobulins
Figure 12. Product Picture of Rabies Immunoglobulins
Figure 13. Product Picture of Tetanus Immunoglobulins
Figure 14. Product Picture of Rho(D) Immunoglobulins
Figure 15. Product Picture of Herpes Zoster Immune Globulin
Figure 16. Product Picture of Other
Figure 17. Global Hyperimmune Globulins Sales Market Share by Type in 2025
Figure 18. Global Hyperimmune Globulins Revenue Market Share by Type (2020-2025)
Figure 19. Hyperimmune Globulins Consumed in Government Institutions
Figure 20. Global Hyperimmune Globulins Market: Government Institutions (2020-2025) & (K Units)
Figure 21. Hyperimmune Globulins Consumed in Private Sector
Figure 22. Global Hyperimmune Globulins Market: Private Sector (2020-2025) & (K Units)
Figure 23. Hyperimmune Globulins Consumed in Other
Figure 24. Global Hyperimmune Globulins Market: Other (2020-2025) & (K Units)
Figure 25. Global Hyperimmune Globulins Sale Market Share by Application (2024)
Figure 26. Global Hyperimmune Globulins Revenue Market Share by Application in 2025
Figure 27. Hyperimmune Globulins Sales by Company in 2025 (K Units)
Figure 28. Global Hyperimmune Globulins Sales Market Share by Company in 2025
Figure 29. Hyperimmune Globulins Revenue by Company in 2025 ($ millions)
Figure 30. Global Hyperimmune Globulins Revenue Market Share by Company in 2025
Figure 31. Global Hyperimmune Globulins Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Hyperimmune Globulins Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 34. Americas Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 35. APAC Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 36. APAC Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 37. Europe Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 38. Europe Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 41. Americas Hyperimmune Globulins Sales Market Share by Country in 2025
Figure 42. Americas Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Figure 43. Americas Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 44. Americas Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 45. United States Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Hyperimmune Globulins Sales Market Share by Region in 2025
Figure 50. APAC Hyperimmune Globulins Revenue Market Share by Region (2020-2025)
Figure 51. APAC Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 52. APAC Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 53. China Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 57. India Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Hyperimmune Globulins Sales Market Share by Country in 2025
Figure 61. Europe Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Figure 62. Europe Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 63. Europe Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 64. Germany Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 65. France Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Hyperimmune Globulins Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 72. Egypt Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Hyperimmune Globulins in 2025
Figure 78. Manufacturing Process Analysis of Hyperimmune Globulins
Figure 79. Industry Chain Structure of Hyperimmune Globulins
Figure 80. Channels of Distribution
Figure 81. Global Hyperimmune Globulins Sales Market Forecast by Region (2026-2031)
Figure 82. Global Hyperimmune Globulins Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Hyperimmune Globulins Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Hyperimmune Globulins Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Hyperimmune Globulins Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Hyperimmune Globulins Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Hyperimmune Globulins
Figure 2. Hyperimmune Globulins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperimmune Globulins Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hyperimmune Globulins Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hyperimmune Globulins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hyperimmune Globulins Sales Market Share by Country/Region (2024)
Figure 10. Hyperimmune Globulins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Hepatitis B Immunoglobulins
Figure 12. Product Picture of Rabies Immunoglobulins
Figure 13. Product Picture of Tetanus Immunoglobulins
Figure 14. Product Picture of Rho(D) Immunoglobulins
Figure 15. Product Picture of Herpes Zoster Immune Globulin
Figure 16. Product Picture of Other
Figure 17. Global Hyperimmune Globulins Sales Market Share by Type in 2025
Figure 18. Global Hyperimmune Globulins Revenue Market Share by Type (2020-2025)
Figure 19. Hyperimmune Globulins Consumed in Government Institutions
Figure 20. Global Hyperimmune Globulins Market: Government Institutions (2020-2025) & (K Units)
Figure 21. Hyperimmune Globulins Consumed in Private Sector
Figure 22. Global Hyperimmune Globulins Market: Private Sector (2020-2025) & (K Units)
Figure 23. Hyperimmune Globulins Consumed in Other
Figure 24. Global Hyperimmune Globulins Market: Other (2020-2025) & (K Units)
Figure 25. Global Hyperimmune Globulins Sale Market Share by Application (2024)
Figure 26. Global Hyperimmune Globulins Revenue Market Share by Application in 2025
Figure 27. Hyperimmune Globulins Sales by Company in 2025 (K Units)
Figure 28. Global Hyperimmune Globulins Sales Market Share by Company in 2025
Figure 29. Hyperimmune Globulins Revenue by Company in 2025 ($ millions)
Figure 30. Global Hyperimmune Globulins Revenue Market Share by Company in 2025
Figure 31. Global Hyperimmune Globulins Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Hyperimmune Globulins Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 34. Americas Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 35. APAC Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 36. APAC Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 37. Europe Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 38. Europe Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Hyperimmune Globulins Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Hyperimmune Globulins Revenue 2020-2025 ($ millions)
Figure 41. Americas Hyperimmune Globulins Sales Market Share by Country in 2025
Figure 42. Americas Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Figure 43. Americas Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 44. Americas Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 45. United States Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Hyperimmune Globulins Sales Market Share by Region in 2025
Figure 50. APAC Hyperimmune Globulins Revenue Market Share by Region (2020-2025)
Figure 51. APAC Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 52. APAC Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 53. China Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 57. India Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Hyperimmune Globulins Sales Market Share by Country in 2025
Figure 61. Europe Hyperimmune Globulins Revenue Market Share by Country (2020-2025)
Figure 62. Europe Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 63. Europe Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 64. Germany Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 65. France Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Hyperimmune Globulins Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Figure 72. Egypt Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Hyperimmune Globulins Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Hyperimmune Globulins in 2025
Figure 78. Manufacturing Process Analysis of Hyperimmune Globulins
Figure 79. Industry Chain Structure of Hyperimmune Globulins
Figure 80. Channels of Distribution
Figure 81. Global Hyperimmune Globulins Sales Market Forecast by Region (2026-2031)
Figure 82. Global Hyperimmune Globulins Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Hyperimmune Globulins Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Hyperimmune Globulins Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Hyperimmune Globulins Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Hyperimmune Globulins Revenue Market Share Forecast by Application (2026-2031)
